Sputnik V for export produced at more than 10 sites in 4 cou

Sputnik V for export produced at more than 10 sites in 4 countries


Sputnik V for export produced at more than 10 sites in 4 countries
Head of the Russian Direct Investment Fund Kirill Dmitriev said, that Sputnik V will be produced by leading pharmaceutical companies
MOSCOW, January 21. /TASS/. Over 10 sites in India, China, Brazil and South Korea produce the Sputnik V vaccine against the coronavirus for foreign supplies, Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with the Russia-24 TV channel on Thursday.
"[For export] we have more than five production sites in India, we have one site in Korea , in China there are also three companies, in Brazil it’s an authorized company," he said.

Related Keywords

China , Moscow , Moskva , Russia , India , South Korea , Brazil , Russian , Kirill Dmitriev , Gamaleya National Research Center , Head Of The Russian Direct Investment Fund , Microbiology Of The Russian Healthcare Ministry , Russian Direct Investment Fund , Russian Healthcare , சீனா , மாஸ்கோ , மோசிக்குவா , ரஷ்யா , இந்தியா , தெற்கு கொரியா , பிரேசில் , ரஷ்ய , தலை ஆஃப் தி ரஷ்ய நேரடி முதலீடு நிதி , நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய சுகாதாரம் அமைச்சகம் , ரஷ்ய நேரடி முதலீடு நிதி , ரஷ்ய சுகாதாரம் ,

© 2025 Vimarsana